Disease burden and treatment sequence of polymyositis and dermatomyositis patients in Japan: a real-world evidence study.

High concomitant immunosuppressant and systemic steroid prescriptions in first LoT recommend early optimal treatment to manage PM/DM. Although inpatient costs are low, outpatient dispensation costs increase overall economic burden.